Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
Clinical Nuclear Medicine|October 14, 2015
Localization of Radiolabeled Somatostatin Analogs in the SpleenMarleen Melis, Daniel Kaemmerer, Jan de Swart, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
Locoregional delivery of adenoviral vectorsMaarten ter Horst, Suzanne M Verwijnen, Eric Brouwer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2016
Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine XenograftsCostanza Santini, Joeri Kuil, Anton Bunschoten, et al.EJNMMI Radiopharmacy and Chemistry|March 23, 2018
Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapyHo Sze Chan, Erik de Blois, Mark W Konijnenberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2018
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of PrincipleKristina Westerlund, Mohamed Altai, Bogdan Mitran, et al.Theranostics|August 30, 2016
Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor OlaparibJulie Nonnekens, Melissa van Kranenburg, Cecile E M T Beerens, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapyWouter A P Breeman, Marion de Jong, Jack L Erion, et al.Plos One|September 8, 2011
Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approachLejla Alic, Joost C Haeck, Karin Bol, et al.Seminars in Nuclear Medicine|April 20, 2002
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findingsMarion De Jong, Roelf Valkema, Francois Jamar, et al.Bioconjugate Chemistry|March 23, 2010
Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluationSusan Roosenburg, Peter Laverman, Lieke Joosten, et al.Pageof 20